Hi-Risk/Recurrent/Advanced PCa Video Chat, Nov 4, 2024

Hi-Risk/Recurrent/Advanced PCa Video Chat, Nov 4, 2024

Hi-Risk/Recurrent/Advanced PCa Video Chat, Nov 4, 2024

(marathon session – hang in to the end for Editor’s Pick!)
MEDICARE RENEWAL – If you are comparing Traditional Medicare + Medigap to Medicare Advantage, please read this AnCan Blog Post: https://ancan.org/medicare-health-insurance-choices/
…and for more on Medicare drug costs in 2025 https://ancan.org/more-on-medicare-2025-drug-costs-for-2025/
AnCan is grateful to the following sponsors for making this recording possible: Bayer, Foundation Medicine, Janssen, Myriad Genetics, Novartis, Telix & Blue Earth Diagnostics.
If you missed any recent recordings, you’ll find a full list either on our YouTube Playlist or visit our Blog Post https://ancan.org/our-recent-blog-posts-in-case-you-missed-them/   Sign up for our Blog by checking the New Blog box at https://ancan.org/contact-us/
AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
AnCan’s Prostate Cancer Forum is back (https://ancan.org/forums). If you’d like to comment on anything you see in our Recordings or read in our Reminders, just sign up and go right ahead. You can also click on the Forum icon at the top right of the webpage.
All AnCan’s groups are free and drop-in … join us in person sometime!
Join our other free and drop in groups:
Editor’s Pick: T doesn’t drop after Eligard shot – Dr. Jeff asks if it was given sub-cu (right) or IM (wrong)?? – rd
Topics Discussed
Newbie navigated to GU MO for 2nd opinion; better VA care in SF than Sacto; extensive mets takes AnCan’r by surprise; finally starting HT after 11 yrs; PSA of 0.6 calls for PSMA scan and resumption of Tx; in reverse – 4 yrs of doublet may allow break; KP approves HDR brachy – but where?; ctDNA trial; compare SBRT + IMRT to all IMRT; orgo dropped for mono daro; getting up once a night should be paradise; spin wheels at KP or listen to AnCan; wait on GU MO until after salvage RT; DR. Jeff asks if Eligard shot was administered correctly when T doesn’t drop?
Chat Log

Len Sierra sent: 6:24 PM    Sampat specializes in GI malignancies

Alfredo in Houston, TX sent: 6:29 PM https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1459- URL for NCCN guideline

Matt M – Sac sent: 6:31 PM radiation is part of the triplet therapy tree as well yes? Or can be one of the “three”? Oligometastatic is “low volume” metastasis correct? Generally less than 5?

Alfredo in Houston, TX sent: 6:36 PM Enzalutamide, sold under the brand name Xtandi

AnCan – rick sent: 6:39 PM Paller https://www.hopkinsmedicine.org/profiles/results/directory/profile/3138167/channing-paller

Brian Haack – Eagle, ID sent: 6:41 PM https://www.prostatecancer.news/2023/05/xtandi-enzalutamide-adt-slows.html   https://www.prostatecancer.news/2022/09/short-term-androgen-annihilation-in-non.html

Len Sierra sent: 6:42 PM ENZAMET is the triplet therapy with enzalutamide

Julian – Houston sent: 6:45 PM https://pmc.ncbi.nlm.nih.gov/articles/PMC10136811/#B10-curroncol-30-00332 – Triplet Therapy in Metastatic Castrate Sensitive Prostate Cancer (mCSPC)—A Potential New Standard of Care

Alfredo in Houston, TX sent: 6:52 PM Genitourinary medical oncologist

Alfredo in Houston, TX sent: 6:58 PM EMBRLABS.COM

AnCan – rick sent: 6:59 PM Franklin Huang https://www.ucsfhealth.org/providers/dr-franklin-huang

AnCan – rick sent: 7:02 PM PROMISE https://www.prostatecancerpromise.org/?utm_campaign=ANCAN&utm_medium=link&utm_source=Webinar

Julian – Houston sent: 7:11 PM  Cheng https://www.fredhutch.org/en/provider-directory/heather-h-cheng.html

AnCan – rick sent: 7:12 PM http://cancer.ucsf.edu/people/profiles/aggarwal_rahul.7339   https://www.med.upenn.edu/apps/faculty/index.php/g275/p8392223 Dr. Narayan https://www.foxchase.org/daniel-geynisman

Richard Tolbert sent: 7:51 PM Hello Dr. Jeff, I had 19 radiation treatments. A 3 month Eligard shot when hospitalized. I am on both Orgovyx and Xtandi.

Matt M – Sac sent: 7:57 PM Hi Guys, Solid night. gotta bounce. See you down the road…

Steve Roux, North Michigan sent: 7:58 PM Good meeting this week, thanks guys! I need to check out for dinner and personal tasks. See you next week.!

Alfredo in Houston, TX sent: 8:49 PM Goodnight everyone and Thank You – I learn something at every session.

dan: alexandria, sent: 8:03 PM Thanks guys…. gotta go.

Michael – Denver sent: 8:32 PM Tx everyone. Good nite.

Our Recent Blog Posts – In Case You Missed Them

Our Recent Blog Posts – In Case You Missed Them

Editor’s Note: We know you’ve missed receiving email notifications about our blog posts. Now that we are up and running on the new system via mailchimp (the same system you receive our group reminders on), here are the posts may have missed. They are categorized for your connivence. Enjoy!


Hi-Risk/Recurrent/Advanced PCa Video Chat Recordings

 


General Prostate Cancer 

 


Solo Arts Heal

 


Veterans

 


Webinars

 


Pancreatic Cancer

 


RMC

 


 

Hi-Risk/Recurrent/Advanced PCa Video Chat, Nov 4, 2024

Hi-Risk/Recurrent/Advanced PCa Video Chat, June 17, 2024

Hi-Risk/Recurrent/Advanced PCa Video Chat, June 17, 2024

 

AnCan is grateful to the following sponsors for making this recording possible: Bayer, Foundation Medicine, Janssen, Myriad Genetics, Novartis, Telix & Blue Earth Diagnostics.
AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
AnCan’s Prostate Cancer Forum is back (https://ancan.org/forums). If you’d like to comment on anything you see in our Recordings or read in our Reminders, just sign up and go right ahead. You can also click on the Forum icon at the top right of the webpage.
All AnCan’s groups are free and drop-in … join us in person sometime!
Join our other free and drop in groups:
Editor’s pick: “Do no harm” – does that also mean waiting to start HT? Good debate ensues! (rd)
Topics Discussed:
All good with The General; TP53 and radiation; best combos with which to start HT on recurrence; pre-treatment PSMA reveals Nx and changes treatment decision; stopping Orgovyx after 13 months may prove a good move; switching to 3 mo. from 6 mo. LHRH Depot; weight gain on LHRH; spot too close to bladder for safe RT – stick with HT alone; more rowers than just ardee; our mountain climber’s doing very well and happy with his GU MO; slow albeit steady climb in PSA shows no source – intervene with HT or wait?; starting HT on Lupron and testicular pain – any connection?
Chat Log
APOLOGIES but a GoTo glitch only downloaded these 2 posts – who knows why??? If anyone who attended has entire Chat transcript, please forward to rd@rickd13.sg-host.com
Jeff Marchi: Withings Body+ Scale. Synchs to your phone
Alan Babcock sent: 6:40 PM:  I have to go.
Hi-Risk/Recurrent/Advanced PCa Video Chat, Nov 4, 2024

Hi-Risk/Recurrent/Advanced PCa Video Chat, April 23, 2024

Hi-Risk/Recurrent/Advanced PCa Video Chat, April 15, 2024

AnCan is grateful to the following sponsors for making this recording possible: Bayer, Foundation Medicine, Janssen, Myriad Genetics, Novartis, Telix & Blue Earth Diagnostics.
AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
AnCan’s Prostate Cancer Forum is back (https://ancan.org/forums). If you’d like to comment on anything you see in our Recordings or read in our Reminders, just sign up and go right ahead. You can also click on the Forum icon at the top right of the webpage.
All AnCan’s groups are free and drop-in … join us in person sometime!
Join our other free and drop in groups:
Editor’s Pick: What do medical medical marijuana and estradiol (E2) have in common? … cardiovascular risks (rd)
Topics Discussed
Is this Newbie getting enough radiation for his high risk situation?; darolutamide monotherapy or maybe a drug holiday?; ARX517 trial – PSMA antibody drug conjugate that carries cytotoxic payload; addressing sleep issues; otc CBN; medical marijuana comes with cardiovascular risks; switching your provider for cause; estradiol and phytoestrogens; early success with AR degrader ARV766; delaying Pluvicto #3 and considering PARP-i; is it a flare or progression?; fenbendazole
Chat Log
Hi-Risk/Recurrent/Advanced PCa Video Chat, Nov 4, 2024

Hi-Risk/Recurrent/Advanced PCa Video Chat, April 1, 2024

Hi-Risk/Recurrent/Advanced PCa Video Chat, April 1, 2024

AnCan is grateful to the following sponsors for making this recording possible: Bayer, Foundation Medicine, Janssen, Myriad Genetics, Myovant, Telix & Blue Earth Diagnostics.

View AnCan’s patient-centered selection of papers and presentations from ASCO GU 2024, one of the top conferences on prostate cancer treatment: • ASCO GU 2024 conference highlights https://www.youtube.com/watch?v=YweU8hjA0Lw&t=2s

AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.

AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.

AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download

AnCan’s Prostate Cancer Forum is back (https://ancan.org/forums). If you’d like to comment on anything you see in our Recordings or read in our Reminders, just sign up and go right ahead. You can also click on the Forum icon at the top right of the webpage.

All AnCan’s groups are free and drop-in … join us in person sometime! You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/ Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/

Join our other free and drop in groups: Men (Only) Speaking Freely…1st & 3rd Thursdays @ 8.00 pm Eastern https://ancan.org/men-speaking-freely/ Veterans Healthcare Navigation… 4th Thursday @ 8.00 pm Eastern https://ancan.org/veterans/

Editor’s Pick: Androgen Receptor degrader ARV766 arrives ahead of its webinar later this year (rd)

Topics Discussed

Diagnosed at 52 and concerned about recurrence at 61; pulse and bloods back to normal – was it the RT?; Metastatic Directed Therapy is not for everyone; starting AR degrader ARV766 trial; issues arising from RT proctitis and hemorrhoids; military vs civilian medical care; questioning pembrolizumab and its toxicity with TMB of 8.6?; abscopal effect from RT with Keytruda

Chat Log